290 related articles for article (PubMed ID: 23261366)
1. Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.
Jesenak M; Majtan J; Rennerova Z; Kyselovic J; Banovcin P; Hrubisko M
Int Immunopharmacol; 2013 Feb; 15(2):395-9. PubMed ID: 23261366
[TBL] [Abstract][Full Text] [Related]
2. Anti-allergic effect of Pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.
Jesenak M; Hrubisko M; Majtan J; Rennerova Z; Banovcin P
Phytother Res; 2014 Mar; 28(3):471-4. PubMed ID: 23744488
[TBL] [Abstract][Full Text] [Related]
3. Pleuran (β-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes.
Bergendiova K; Tibenska E; Majtan J
Eur J Appl Physiol; 2011 Sep; 111(9):2033-40. PubMed ID: 21249381
[TBL] [Abstract][Full Text] [Related]
4. Effect of Pleuran (β-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes.
Bobovčák M; Kuniaková R; Gabriž J; Majtán J
Appl Physiol Nutr Metab; 2010 Dec; 35(6):755-62. PubMed ID: 21164546
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Tract Infections and the Role of Biologically Active Polysaccharides in Their Management and Prevention.
Jesenak M; Urbancikova I; Banovcin P
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28726737
[TBL] [Abstract][Full Text] [Related]
6. Pleuran (β-glucan from Pleurotus ostreatus ): an effective nutritional supplement against upper respiratory tract infections?
Majtan J
Med Sport Sci; 2012; 59():57-61. PubMed ID: 23075555
[TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
[TBL] [Abstract][Full Text] [Related]
8. Beta-(1,3/1,6)-D-glucan from
Rennerova Z; Picó Sirvent L; Carvajal Roca E; Paśnik J; Logar M; Milošević K; Majtan J; Jesenak M
Front Pediatr; 2022; 10():999701. PubMed ID: 36324817
[TBL] [Abstract][Full Text] [Related]
9. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.
Bousquet J; Fiocchi A
Paediatr Drugs; 2006; 8(4):235-43. PubMed ID: 16898854
[TBL] [Abstract][Full Text] [Related]
10. β-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis.
Jesenak M; Urbancek S; Majtan J; Banovcin P; Hercogova J
J Dermatolog Treat; 2016 Aug; 27(4):351-4. PubMed ID: 26654776
[TBL] [Abstract][Full Text] [Related]
11. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
[TBL] [Abstract][Full Text] [Related]
12. Immunoactivation by pidotimod in children with recurrent respiratory infections.
Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation with β-glucan from
Spacek J; Vocka M; Zavadova E; Konopasek B; Petruzelka L
Immunotherapy; 2022 Jan; 14(1):31-40. PubMed ID: 34784798
[TBL] [Abstract][Full Text] [Related]
15. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
Niu H; Wang R; Jia YT; Cai Y
Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
[TBL] [Abstract][Full Text] [Related]
16. [Experience with the use of IRS-19 for the rehabilitation of children after acute respiratory infections].
Mukhomedzianova LV; Andriianova IV; Kashirtseva IA
Vestn Otorinolaringol; 2012; (2):61-2. PubMed ID: 22810641
[TBL] [Abstract][Full Text] [Related]
17. [Value of Imocur in the prevention of recurrent infections in children under six years of age. Results of a multicenter, placebo-controlled trial].
Paupe J
Ann Pediatr (Paris); 1990 Sep; 37(7):475-9. PubMed ID: 2256645
[TBL] [Abstract][Full Text] [Related]
18. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Pleuran (
Urbancikova I; Hudackova D; Majtan J; Rennerova Z; Banovcin P; Jesenak M
Evid Based Complement Alternat Med; 2020; 2020():8562309. PubMed ID: 32419831
[TBL] [Abstract][Full Text] [Related]
20. Effects of pleuran (beta-glucan isolated from Pleurotus ostreatus) on experimental colitis in rats.
Nosál'ová V; Bobek P; Cerná S; Galbavý S; Stvrtina S
Physiol Res; 2001; 50(6):575-81. PubMed ID: 11829318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
